Perphenazine
Back to searchMolecule Structure
Scientific Name
Perphenazine
Description of the Drug
Perphenazine is a phenothiazine used to treat schizophrenia as well as nausea and vomiting.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00850
http://www.drugbank.ca/drugs/DB00850
Brand Name(s)
Chlorpiprazine, Decentan, Fentazin, Perphenazine, Perphenazine Fendizoate, Trilafon, Trilafon-La
Company Owner(s)
Pharmaceutical Assoc Inc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Fosun Pharma Usa Inc, Schering Corp Sub Schering Plough Corp, Sandoz Inc, Sun Pharmaceutical Industries Inc, New River Pharmaceuticals Inc, Watson Laboratories Inc, Wilshire Pharmaceuticals Inc, Par Pharmaceutical Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dopamine D2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL217 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL42125 |
| PharmGKB | PA450882 |
| Human Metabolome Database | HMDB0014988 |
| DrugBank | DB00850 |
| PubChem: Thomson Pharma | 14903848 |
| PubChem | 4748 |
| Mcule | MCULE-6019566915 |
| LINCS | LSM-2224 |
| Nikkaji | J1.387K |
| BindingDB | 50130273 |
| EPA CompTox Dashboard | DTXSID1023441 |
| DrugCentral | 2113 |
| Brenda | 8452 |
| ChemicalBook | CB6687009 |
| Guide to Pharmacology | 209 |
| rxnorm | PERPHENAZINE |
| PubChem: Drugs of the Future | 12013414 |
| KEGG Ligand | C07427 |
| ChEBI | 8028 |
| ZINC | ZINC000019228902 |
